-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Mitarbeiter
15.000
Biocon Limited outperformed den DAX um +33 % vom 11.10.2013 bis 28.04.2014
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Biocon Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Biocon Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Biocon Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Biocon Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
34 News & Informationen zur Biocon Limited Aktie
Kiran Mazumdar-Shaw Meets Karnataka CM To Discuss various Development Issues Of Banglore
The meeting was also attended by Kris Gopalakrishnan, Co-founder Infosys, Nikhil Kamath founder Zerodha, True Beacon, V. Mohandas Pai, Chairman of Manipal Global Education (Manipal University), and Anil Shetty entrepreneur.
, , kiran mazumdar-shaw, nikhil kamath, Zerodha
Biocon Share Price: Biocon shares rise 0.6% as Sensex slides
A total of 16,238 shares changed hands on the counter till 12:13PM (IST)
Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 – Increasing Demand For Personalized Medicine To Bode Well For Market Growth
DUBLIN, Aug. 4, 2021 /PRNewswire/ — The “Global Proteomics Market, By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery,
Windlas Biotech IPO: 10 key things to know before the issue opens
Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations CDMOs in terms of revenue, with focus on the chronic therapeutic category.
Healthcare funds that weathered the industry’s cyclicality
Funds managed by UTI, SBI and Nippon offer time-tested performance
Stock market update: Nifty Pharma index falls 0.32%
The Nifty Pharma index closed 0.32 per cent down at 13920.35.
Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar product
Diabetes cure: USFDA’s designation of Semglee (insulin glargine) as interchangeable with Lantus (insulin glargine of Sanofi) means that Semglee may now be substituted for the reference product at the pharmacy without the intervention of the prescriber.
Nifty Pharma tanks 4.33%, records worst intra-day fall since December; Dr Reddy’s plummets 10%
Nifty Pharma index came under attack from bears on Tuesday forcing the sectoral gauge to close 4.33% lower, the worst single-day fall recorded by the index since December last year.
Buzzing Stocks: L&T, Axis Bank, Tata Motors and other stocks in news today
Stocks In the News: Check out the companies making the biggest headlines before the opening bell.
Ahead of Market: 12 things that will decide stock action on Tuesday
Mazhar Mohammad of Chartviewindia.in said the market appears to be in a rangebound move as Nifty keeps faltering at the 15,900 level.
Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
Under the terms of the deal, Biocon Biologics will get access to the clinical and non-clinical data from Adagio’s EUA submission to the U.S. Food and Drug Administration to seek approvals in the emerging markets.
Biocon net profit falls 35% to Rs 108 crore in Apr-Jun
Consolidated revenue of the company stood at Rs 1,807.8 crore for the quarter under consideration. It was at Rs 1,712.1 crore for the same period a year ago.
Stock market update: Nifty Pharma index advances 0.15%
The Nifty Pharma index closed 0.15 per cent up at 14597.85.
Biocon Share Price: Biocon shares down 0.61% as Nifty gains
The stock quoted a 52-week high price of Rs 487.7 and low of Rs 363.3.
Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr
Read more about Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr on Business Standard. Biotechnology major Biocon has reported a 35.39 per cent decline in its consolidated net profit at Rs 108.4 crore for the quarter ended June 30, 2021 mainly on account of its share of loss in associate startup entity Bicara Therapeutics Inc.The
Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
Worldwide Rapid Acting Insulin Industry to 2027 – Players Include Merck & Co, Sanofi and Novo Nordisk Among Others
/PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report…
Worldwide Rapid Acting Insulin Industry To 2027 – Players Include Merck & Co, Sanofi And Novo Nordisk Among Others
DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook,
Buzzing Stocks: HUL, Bajaj Finance, Indiabulls Housing Finance and other stocks in news today
Stocks In the News: Check out the companies making the biggest headlines before the opening bell.
SGX Nifty up 135 points; here's what changed for market while you were sleeping
Asian shares rose on Thursday, clawing back some of the week's losses as investors reassessed economic worries over the impact of a fast-spreading coronavirus variant. MSCI's broadest index of Asia-Pacific shares outside Japan was up by 0.95 per cent. Japanese market was shut for the day on account of public holiday.
Top 10 things to know before the market opens
Trends on SGX Nifty indicate a gap-up opening for the index in India with a 109 points gain.
Trade setup for Thursday: Top 15 things to know before Opening Bell
Rajesh Palviya of Axis Securities feels on the downside, any violation of an intraday support zone of 15,580 levels may cause profit booking towards 15,500-15,400 levels.
Stock market update: Nifty Pharma index falls 1.3%
The Nifty Pharma index closed 1.3 per cent down at 14479.2.
Movers & Shakers | 10 stocks that moved the most last week
Experts expect the consolidation to continue in coming week too, with the market keeping a watch on new variant of Covid-19 and macroeconomic data along with monsoon progress, while the stock specific action could continue with the beginning of June quarter earnings season.
Market ends lower in a volatile week; mid & small-caps continue to outperform
key highlights from the week gone by
Sebi needs to act rationally in insider trading judgements: Kiran Mazumdar-Shaw
Mazumdar-Shaw's tweet came after Sebi barred Allegro Capital and one of its senior executives from the securities market for one year in a case related to alleged insider trading activities in the shares of Biocon.
Biocon Share Price: Biocon shares down 0.63% as Sensex falls
A total of 24,606 shares changed hands on the counter till 01:00PM (IST)
Global Erythropoietin Drugs Market Research Report 2021-2027: Biologics, Biosimilars, Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa
/PRNewswire/ — The “Global Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Regional Outlook, Industry Analysis Report and Forecast,…
Taking Stock: Sensex ends with marginal losses after hitting all-time high; banks outperform
BSE midcap index ended marginally higher, while smallcap index fell 0.26 percent.
Biocon shares underperform pharma index in a year; global brokerage retains sell
Global research firm CLSA has maintained sell on the stock with target at Rs 260 per share. It is of the view that cash flow remained negative for an eighth consecutive year in FY21 with operating cash flow falling 24 percent YoY and capex intensity remaining high.
Insider trading case: SEBI bars Biocon's official from securities market for 3 months, levies fine
Biocon had announced information relating to its collaboration with Sandoz and the period of unpublished price sensitive information (UPSI) was from December 20, 2017 to January 18, 2018, The Securities and Exchange Board of India (Sebi) noted in an order passed late on Wednesday.
Taking Stock: Market fails to hold record high with Nifty below 15,850. PSU banks stand out
More than 400 stocks, including Tata Consumer Products, Nelco, Laurus Labs and Shree Renuka Sugars, hit a fresh 52-week high on the BSE
Biocon Share Price: Biocon shares down 0.41% as Sensex rises
A total of 102,002 shares changed hands on the counter till 01:21PM (IST)